Medications such as Ozempic and Mounjaro are composed of molecules called acylated peptides that are designed to circulate in the body and regulate insulin production. This enables adults with type 2 diabetes to take a weekly injection instead of monitoring their insulin levels every few hours. With slight modification, this class of therapeutics is also approved for weight-loss use in the treatment of obesity.